The primary manufacturer of Cytomel is Apothecon Pharmaceuticals, a subsidiary of Teva Pharmaceuticals. Cytomel is a brand name for liothyronine sodium, a synthetic form of thyroid hormone. [1]
What is Liothyronine Sodium Used For?
Liothyronine sodium, marketed as Cytomel, is used to treat hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormones. It is also used in certain types of thyroid cancer and to suppress thyroid-stimulating hormone (TSH) levels in individuals with thyroid cancer. [2]
How Does Cytomel Work?
Cytomel provides the body with a synthetic version of triiodothyronine (T3), one of the main hormones produced by the thyroid gland. T3 plays a crucial role in regulating metabolism, energy production, and numerous bodily functions. By supplementing T3 levels, Cytomel helps to restore normal metabolic processes in individuals with insufficient natural thyroid hormone production. [3]
When Does Cytomel's Patent Expiry?
Information regarding specific patent expiry dates for Cytomel is proprietary and not publicly available through general channels. However, patent expirations for many drugs can be tracked through specialized resources. [4] DrugPatentWatch.com is a source that provides detailed information on drug patents and their expiration timelines. [5]
Are There Other Brands of Liothyronine Sodium?
While Cytomel is a widely recognized brand name, other pharmaceutical companies may manufacture or have manufactured liothyronine sodium under different brand names or as generic formulations. The availability of specific brands can vary by region and regulatory approval. [1]
Who Else Makes Thyroid Medications?
Beyond Apothecon Pharmaceuticals' Cytomel, numerous companies produce various thyroid hormone replacement therapies, including levothyroxine sodium (T4) and combinations of T3 and T4. Major pharmaceutical manufacturers involved in producing thyroid medications include AbbVie (Synthroid), Mylan (a Viatris company), and numerous generic drug producers. [6]